Anslei Brown, NP | |
1720 Old Reynolds St, Waycross, GA 31501-1036 | |
(912) 283-1359 | |
Not Available |
Full Name | Anslei Brown |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 1720 Old Reynolds St, Waycross, Georgia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134799000 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | RN254733 (Georgia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Anslei Brown, NP 1720 Old Reynolds St, Waycross, GA 31501-1036 Ph: (912) 283-1359 | Anslei Brown, NP 1720 Old Reynolds St, Waycross, GA 31501-1036 Ph: (912) 283-1359 |
News Archive
Teva Pharmaceutical Industries Ltd. announced today that it has entered into two definitive agreements with AstraZeneca to settle patent litigation regarding Teva's U.S. generic versions of AstraZeneca's Prilosec® (omeprazole) and Nexium® (esomeprazole), including all claims for patent infringement and damages.
Women who go into early menopause are twice as likely to suffer from coronary heart disease and stroke, new Johns Hopkins-led research suggests. The association holds true in patients from a variety of different ethnic backgrounds, the study found, and is independent of traditional cardiovascular disease risk factors, the scientists say.
Catalyst Rx, the pharmacy benefit management (PBM) subsidiary of Catalyst Health Solutions, Inc., announced the award of a new service contract with Wellmark following a competitive bid process. Wellmark does business as Wellmark Blue Cross and Blue Shield of Iowa and its subsidiaries include Wellmark Blue Cross and Blue Shield of South Dakota and Wellmark Health Plan of Iowa, Inc. Wellmark Blue Cross and Blue Shield is an independent licensee of the Blue Cross and Blue Shield Association.
Celgene International Sàrl announced that data from the planned second interim analysis (median follow-up of 21 months) of a phase III, randomized, double-blind study of continuous REVLIMID (lenalidomide) for the treatment of elderly patients with newly diagnosed multiple myeloma show improvement in progression-free survival, the primary endpoint of the study.
› Verified 7 days ago
Barbara D Pittman, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 615a Pendleton St, Waycross, GA 31501 Phone: 912-548-0710 Fax: 912-548-0071 | |
Robert Scott Jacobs, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 403a Lister St, Waycross, GA 31501 Phone: 912-283-4422 Fax: 912-283-4866 | |
Mr. James Aaron Houser, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1206 Alice St, Waycross, GA 31501 Phone: 912-285-1140 Fax: 912-285-1125 | |
Dawn Lynn Driggers, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1710 1/2 Alice St, Waycross, GA 31501 Phone: 912-614-3768 | |
Kala Hodges, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 409 Uvalda St, Waycross, GA 31501 Phone: 229-391-3500 | |
Ms. Andrea M Deloach, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 711 Knight Ave, Waycross, GA 31501 Phone: 912-283-9423 Fax: 912-283-2946 | |
Mrs. Jennifer Miller Rafus, M.S., FNP, LIC. AC. Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 615a Pendleton St, Waycross, GA 31501 Phone: 912-548-0710 |